BEIJING, July 28, 2011 /PRNewswire-Asia-FirstCall/ — Concord
Medical Services Holdings Limited (“Concord Medical” or the
“Company”) (NYSE:
CCM), the operator of the largest network of radiotherapy and
diagnostic imaging centers in China, today announced that on
July 26, 2011 its Board of Directors declared a special dividend of
$0.06 per ordinary share (or $0.18 per American Depositary Share)
on the Company’s outstanding ordinary shares. The total expense for
the special dividend is expected to be about US$8.5 million, based
on the 142,353,532 ordinary shares that were outstanding as of July
28, 2010. Each ADS represents three ordinary shares of the
Company.
The dividends are payable on September 30, 2011, to shareholders
of record at the close of business on August 31, 2011. This is the
Company’s first dividend declared on its ordinary shares since its
initial public offering on December 11, 2009. The underwriters for
the IPO were Morgan Stanley, J.P. Morgan, and CICC.
Mr. Steve Sun, co-chairman and chief financial officer, said,
“The Board of Directors declared this special dividend to provide
shareholders with a tangible recognition of our good growth and
financial performance since our initial public offering in December
2009. The Board expects to establish a long-term dividend policy,
after a thorough analysis of the company’s long-term strategy,
plans, outlook, and anticipated cash needs.”
Safe Harbor StatementThis news release may contain
forward-looking statements. These statements constitute
“forward-looking” statements within the meaning of Section 21E of
the Securities Exchange Act of 1934, as amended, and as defined in
the U.S. Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
“anticipate,” “believe,” “estimate,” “expect,” “forecast,”
“intend,” “may,” “plan,” “project,”
‘/>”/>
